ELANFRA:25E +0.55%84 Capex-to-Operating-Income is 0.00 as of Dec. 2025. GuruFocus rates FRA:25E with a GF Score™ of 84/100 and a GF Value™ of €5.85. The stock has 3 warning signs investors should review. Among 359 Healthcare Providers & Services companies, ELAN ranks worse than 278551.25% on this metric.
Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.
ELAN's Capital Expenditure for the
three
months ended in Dec. 2025 was €0.00 Mil. Its Operating Income for the
three
months ended in Dec. 2025 was €6.74 Mil.
Hence, ELAN's Capex-to-Operating-Income for the
three
months ended in Dec. 2025 was 0.00.
ELAN (FRA:25E) Capex-to-Operating-Income Explanation
Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.
ELAN Capex-to-Operating-Income Related Terms
ELAN Capex-to-Operating-Income Historical Data
* Premium members only.
The historical data trend for ELAN's Capex-to-Operating-Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:25E vs HCA, THC, DVA: Capex-to-Operating-Income Comparison
For the Medical Care Facilities subindustry, ELAN's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ELAN Capex-to-Operating-Income vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, ELAN's Capex-to-Operating-Income distribution charts can be found below:
* The bar in red indicates where ELAN's Capex-to-Operating-Income falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Capex-to-Operating-Income of 0.00 mean?
ELAN (FRA:25E) has a Capex-to-Operating-Income of 0.00 as of Dec. 2025. Capex to Operating Income ratio measures a company's investments in physical assets to its operating income. View historical data on ELAN and its competitors. Over the past decade, ELAN's Capex-to-Operating-Income has ranged from 0.03 to 0.27. According to the industry distribution chart, ELAN ranks #999999 out of 359 companies in the Healthcare Providers & Services industry.
Is ELAN's Capex-to-Operating-Income too high?
ELAN's current Capex-to-Operating-Income is 0.00. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 0.27. Based on the distribution chart, ELAN ranks #999999 out of 359 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, ELAN has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does ELAN's Capex-to-Operating-Income compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, ELAN ranks #999999 out of 359 companies for Capex-to-Operating-Income. This places ELAN in the lower half of its industry. The industry median Capex-to-Operating-Income is 0.51. Historically, ELAN's own Capex-to-Operating-Income has ranged from 0.03 to 0.27 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Capex-to-Operating-Income for a Healthcare Providers & Services company?
The median Capex-to-Operating-Income among Healthcare Providers & Services companies is 0.51, based on 359 companies in the industry. Companies in the top quartile (top 25%) have a Capex-to-Operating-Income significantly above this median, while those in the bottom quartile fall well below. However, Capex-to-Operating-Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Capex-to-Operating-Income mean?
A high Capex-to-Operating-Income can signal that a stock is expensive relative to its fundamentals. Capex to Operating Income ratio measures a company's investments in physical assets to its operating income. View historical data on ELAN and its competitors. For the Healthcare Providers & Services industry, the median Capex-to-Operating-Income is 0.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ELAN's current Capex-to-Operating-Income is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ELAN stock overvalued right now?
ELAN (FRA:25E) has a current Capex-to-Operating-Income of 0.00. The stock's GF Value™ is €5.85, compared to a current price of €3.66 — trading 37.4% below its estimated fair value. The current Capex-to-Operating-Income is 0.00. ELAN's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Capex-to-Operating-Income calculated?
Capex-to-Operating-Income is calculated from a company's financial statements. For ELAN (FRA:25E), the current Capex-to-Operating-Income is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ELAN (FRA:25E) Overvalued in 2026?
Based on GuruFocus' analysis, ELAN stock appears to be undervalued.
The current stock price of €3.66 is trading 37.4% below its estimated GF Value™ of €5.85.
Key valuation signals for FRA:25E:
Capex-to-Operating-Income: 0.00
GF Value™: €5.85 vs. price of €3.66 (37.4% below fair value)
No single metric tells the full story. See the FRA:25E stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ELAN Corp operates in the medical industry. The company provides the CS (Care Support) Set service, which combines the rental of clothing and towels, laundry services, and the provision of daily living goods. The service is offered to individuals in hospitals and nursing care facilities, including nursing homes and other care facilities. The CS Set allows users to access clothing, towels, and daily necessities through a combined rental and supply service.
84GF Score
Get the complete analysis for FRA:25E
Capex-to-Operating-Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:25E has been successfully added to your 
